Diagnosis and treatment of the systemic and cutaneous necrotizing vasculitis syndromes.
Advances in understanding of the spectrum of clinical presentations of patients with systemic and cutaneous necrotizing vasculitis as well as further work on pathogenesis of these conditions has helped with diagnosis of these conditions. Therapies for systemic and cutaneous necrotizing vasculitis are based on disease extent, severity, and concomitant conditions in the individual patient. Future multicenter and multidisciplinary studies will provide improved treatments for these challenging clinical situations.
Allen
N B
NB
Division of Rheumatology, Allergy and Immunology, Duke University Medical Center, Durham, North Carolina, USA.
Bressler
P B
PB
D005544:Forecasting; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D009336:Necrosis; D010488:Polyarteritis Nodosa / Q000175:diagnosis / Q000188:drug therapy; D017445:Skin Diseases, Vascular / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D013577:Syndrome; D014657:Vasculitis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology
D005938:Glucocorticoids; D007166:Immunosuppressive Agents